Business Context and Reporting Period
Company: Microbot Medical Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: February 12, 2026
Reporting Period: Single event date (February 12, 2026)
This filing serves as a Regulation FD disclosure regarding the Company's participation in the International Symposium on Endovascular Therapy (ISET) conference held in Miami Beach, Florida, from February 9-12, 2026.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure and does not contain financial statements or performance metrics.
Material Changes
No material financial changes versus a prior comparable period are reported in this document. The filing focuses solely on the strategic event of featuring the LIBERTY® Endovascular Robotic System at the ISET conference.
Guidance, Outlook, and Management Commentary
- Event Highlight: The Company announced that its LIBERTY® Endovascular Robotic System was featured at the ISET conference.
- Management Commentary: The press release (Exhibit 99.1) is incorporated by reference but the text of the release is not included in the provided filing content.
- Legal Disclaimer: The information furnished in Item 7.01 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and does not constitute an admission of materiality.
Investor Verification Checklist
- Review the full text of the press release (Exhibit 99.1) for specific details on the LIBERTY® system's reception or feedback at the ISET conference.
- Verify if the conference appearance correlates with any upcoming regulatory milestones or commercialization updates not detailed in this 8-K.
- Check subsequent filings for any financial impact or strategic shifts resulting from the conference engagement.